Biological Information

Background Information:

The KILR® Raji ADCC Bioassay Kit is a simple, robust, non-radioactive, dye free cytotoxicity assay to specifically measure direct target cell death in a co-culture. The bioassay kit contains all the materials needed to run the ADCC assay (except effector cells) including ready-to-use cryopreserved target cells, assay plates and optimized reagents. The representative dose-response curve has been generated using the control antibody Rituximab (not included in the kit). The ready-to-use cryopreserved cells have been manufactured to ensure assay reproducibility and faster implementation from screening to characterization and lot release. This bioassay has been optimized for a 96-well format.

Please reach out to Tech Support at DiscoverXSupportUS@discovery.eurofinsus.com for lot specific CoA.

Target Species:

Human

Cell Background:

Raji

Usage

Product Type:

Bioassay Kits

Application:

Potency, Commercial Release & Stability

Kit Components:

KitComponent

Storage Conditions:

Store in vapor phase of liquid nitrogen.

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Cell Based, Qualified

Assay Measures:

Cytotoxicity

Detection Method:

Chemiluminescence

Bioassay Data

INN Drug Name:

Rituximab

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

KILR®